CRISPR Therapeutics AG CRSP:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 8:54 AM EDT
56.01quote price arrow up+0.94 (+1.71%)
Volume
8,547
Close
55.07quote price arrow up+1.26 (+2.34%)
Volume
978,814
52 week range
37.55 - 91.10
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close55.07
  • 52 Week High91.10
  • 52 Week High Date02/22/24
  • 52 Week Low37.55
  • 52 Week Low Date10/23/23

Key Stats

  • Market Cap4.675B
  • Shares Out84.88M
  • 10 Day Average Volume1.25M
  • Dividend-
  • Dividend Yield-
  • Beta1.79
  • YTD % Change-12.03

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close55.07
  • 52 Week High91.10
  • 52 Week High Date02/22/24
  • 52 Week Low37.55
  • 52 Week Low Date10/23/23
  • Market Cap4.675B
  • Shares Out84.88M
  • 10 Day Average Volume1.25M
  • Dividend-
  • Dividend Yield-
  • Beta1.79
  • YTD % Change-12.03

RATIOS/PROFITABILITY

  • EPS (TTM)-1.95
  • P/E (TTM)-28.26
  • Fwd P/E (NTM)-9.95
  • EBITDA (TTM)-202.662M
  • ROE (TTM)-8.17%
  • Revenue (TTM)371.206M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-41.38%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/04/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CRISPR Therapeutics AG

 

Profile

MORE
CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined...
Samarth Kulkarni Ph.D.
Chairman of the Board, Chief Executive Officer
Raju Prasad Ph.D.
Chief Financial Officer
James Kasinger J.D.
General Counsel, Secretary
Address
Baarerstrasse 14
Zug, ZUG
6300
Switzerland

Top Peers

SYMBOLLASTCHG%CHG
RARE
Ultragenyx Pharmaceutical Inc
43.20-0.10-0.23%
INSM
Insmed Inc
25.66+0.07+0.27%
KRYS
Krystal Biotech Inc
160.23+0.56+0.35%
APLS
Apellis Pharmaceuticals Inc
47.49+1.44+3.13%
AXSM
Axsome Therapeutics Inc
74.19-0.70-0.93%